CDEK
← All drugs Report issue

tg103

Recombinant proteinexperimental

Clinical trial activity

11 trials · 4 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
7
Phase 3
3
Phase 4
0

Earliest trial started Jul 31, 2019 (NCT03990090)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2021

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2023

    Earliest Phase 3 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06258148Phase 3Mar 31, 2024Shijiazhuang Pharma Group (CSPC)
NCT06235086Phase 3Mar 31, 2024Shijiazhuang Pharma Group (CSPC)
NCT06226090Phase 2Feb 21, 2024Shijiazhuang Pharma Group (CSPC), Sun Yat-Sen University
NCT05997576Phase 3Sep 1, 2023Shijiazhuang Pharma Group (CSPC), Sun Yat-Sen University
NCT05348122Phase 2Jun 15, 2022Peking University, Shijiazhuang Pharma Group (CSPC)
NCT05299697Phase 2May 20, 2022Shijiazhuang Pharma Group (CSPC), Sun Yat-Sen University
NCT05063253Phase 2Oct 31, 2021Nanjing University, Shijiazhuang Pharma Group (CSPC)
NCT04855292Phase 1May 31, 2021Shijiazhuang Pharma Group (CSPC)
NCT04839744Phase 1Apr 30, 2021Nanjing University, Shijiazhuang Pharma Group (CSPC)
NCT04790006Phase 1Apr 30, 2021Peking University, Shijiazhuang Pharma Group (CSPC)
NCT03990090Phase 1Jul 31, 2019Peking University, Shijiazhuang Pharma Group (CSPC)
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (4)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Shijiazhuang Pharma Group (CSPC)For profit111132019
Peking UniversityAcademic/Hospital3022019
Sun Yat-Sen UniversityAcademic/Hospital3022022
Nanjing UniversityAcademic/Hospital2022021
4 organizations
Page 1 / 1